Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Advances in Therapy
Published in: Advances in Therapy 1/2019

Open Access 01-01-2019 | Review

Canaloplasty in the Treatment of Open-Angle Glaucoma: A Review of Patient Selection and Outcomes

Authors: Ivano Riva, Paolo Brusini, Francesco Oddone, Manuele Michelessi, Robert N. Weinreb, Luciano Quaranta

Published in: Advances in Therapy | Issue 1/2019

Login to get access

Abstract

Canaloplasty is a relatively new non-penetrating surgery for the reduction of intraocular pressure in patients affected by glaucoma. The technique uses a microcatheter to perform a 360 º cannulation of Schlemm’s canal and leaves in place a tension suture providing an inward distension. It aims to restore the physiological outflow pathways of the aqueous humour and is independent of external wound healing. Several studies have shown that canaloplasty is effective in reducing intraocular pressure and has a low rate of complications, especially compared with trabeculectomy, the gold standard for glaucoma surgery. Currently, canaloplasty is indicated in patients with open-angle glaucoma, having a mild to moderate disease, and the combination with cataract phacoemulsification may provide further intraocular pressure reduction. This article reviews canaloplasty indications, results and complications and analyses its outcomes compared with traditional penetrating and non-penetrating techniques.
Literature
1.
Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081–90.CrossRef
2.
Giangiacomo A, Coleman A. Optic disc and visual field changes in primary open angle glaucoma. In: Grehn F, Stamper R, editors. Glaucoma. Berlin, Heidelberg: Springer; 2009. p. 13–21.CrossRef
3.
Goldberg I. Optic disc and visual field changes in primary open angle glaucoma. Aust J Ophthalmol. 1981;9:223–9.CrossRef
4.
De Moraes CG, Liebmann JM, Park SC, et al. Optic disc progression and rates of visual field change in treated glaucoma. Acta Ophthalmol. 2013;91:e86–91.CrossRef
5.
Pillunat LE, Stodtmeister R, Marquardt R, Mattern A. Ocular perfusion pressures in different types of glaucoma. Int Ophthalmol. 1989;13:37–42.CrossRef
6.
Quaranta L, Manni G, Donato F, Bucci MG. The effect of increased intraocular pressure on pulsatile ocular blood flow in low tension glaucoma. Surv Ophthalmol. 1994;38(Suppl):S177–81 (discussion S182).CrossRef
7.
Quaranta L, Katsanos A, Russo A, Riva I. 24-hour intraocular pressure and ocular perfusion pressure in glaucoma. Surv Ophthalmol. 2013;58:26–41.CrossRef
8.
Pillunat LE, Anderson DR, Knighton RW, Joos KM, Feuer WJ. Autoregulation of human optic nerve head circulation in response to increased intraocular pressure. Exp Eye Res. 1997;64:737–44.CrossRef
9.
Ojha P, Wiggs JL, Pasquale LR. The genetics of intraocular pressure. Semin Ophthalmol. 2013;28:301–5.CrossRef
10.
Gordon MO, Beiser JA, Brandt JD, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:714–20 (discussion 829–730).CrossRef
11.
Miglior S, Torri V, Zeyen T, et al. Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study. Am J Ophthalmol. 2007;144:266–75.CrossRef
12.
Gordon MO, Ocular Hypertension Treatment Study G, European Glaucoma Prevention Study G, et al. Validated prediction model for the development of primary open-angle glaucoma in individuals with ocular hypertension. Ophthalmology. 2007;114:10–9.CrossRef
13.
Leske MC, Heijl A, Hussein M, et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121:48–56.CrossRef
14.
The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators. Am J Ophthalmol. 2000;130:429–440.
15.
Musch DC, Gillespie BW, Niziol LM, et al. Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2011;118:1766–73.CrossRef
16.
Garway-Heath DF, Crabb DP, Bunce C, et al. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet. 2015;385:1295–304.CrossRef
17.
Prum BE Jr, Rosenberg LF, Gedde SJ, et al. Primary open-angle glaucoma preferred practice pattern((R)) guidelines. Ophthalmology. 2016;123:P41–111.CrossRef
18.
The European Glaucoma Society. Terminology and guidelines for glaucoma. 4th ed. Savona: PubliComm; 2014. p. 84–6.
19.
Ariano ML, Ball SF. Delayed nonexpulsive suprachoroidal hemorrhage after trabeculectomy. Ophthalmic Surg. 1987;18:661–6.PubMed
20.
Vaziri K, Schwartz SG, Kishor KS, et al. Incidence of postoperative suprachoroidal hemorrhage after glaucoma filtration surgeries in the United States. Clin Ophthalmol. 2015;9:579–84.PubMedPubMedCentral
21.
Patel HY, Danesh-Meyer HV. Incidence and management of cataract after glaucoma surgery. Curr Opin Ophthalmol. 2013;24:15–20.CrossRef
22.
Zacharia PT, Deppermann SR, Schuman JS. Ocular hypotony after trabeculectomy with mitomycin C. Am J Ophthalmol. 1993;116:314–26.CrossRef
23.
Jampel HD, Musch DC, Gillespie BW, et al. Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol. 2005;140:16–22.CrossRef
24.
Susanna R Jr, Takahashi W, Nicolela M. Late bleb leakage after trabeculectomy with 5-fluorouracil or mitomycin C. Can J Ophthalmol. 1996;31:296–300.PubMed
25.
The Fluorouracil Filtering Surgery Study Group. Three-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol. 1993;115:82–92.CrossRef
26.
Yamamoto T, Sawada A, Mayama C, et al. The 5-year incidence of bleb-related infection and its risk factors after filtering surgeries with adjunctive mitomycin C: collaborative bleb-related infection incidence and treatment study 2. Ophthalmology. 2014;121:1001–6.CrossRef
27.
Rulli E, Biagioli E, Riva I, et al. Efficacy and safety of trabeculectomy vs nonpenetrating surgical procedures: a systematic review and meta-analysis. JAMA Ophthalmol. 2013;131:1573–82.CrossRef
28.
Eldaly MA, Bunce C, Elsheikha OZ, Wormald R. Non-penetrating filtration surgery versus trabeculectomy for open-angle glaucoma. Cochrane Database Syst Rev. 2014;15:CD007059.
29.
Fyodorov S. Non penetrating deep sclerectomy in open-angle glaucoma. Eye Microsurg. 1989;2:52–5.
30.
Stegmann R, Pienaar A, Miller D. Viscocanalostomy for open-angle glaucoma in black African patients. J Cataract Refract Surg. 1999;25:316–22.CrossRef
31.
Cameron B, Field M, Ball S, Kearney J. Circumferential viscodilation of Schlemm’s canal with a flexible microcannula during non-penetrating glaucoma surgery. Digit J Ophthalmol. 2006;12:1.
32.
Grieshaber MC. Viscocanalostomy and canaloplasty: ab externo Schlemm’s canal surgery. Dev Ophthalmol. 2017;59:113–26.CrossRef
33.
Cagini C, Peruzzi C, Fiore T, et al. Canaloplasty: current value in the management of glaucoma. J Ophthalmol. 2016;2016:7080475.CrossRef
34.
Brusini P. Canaloplasty in open-angle glaucoma surgery: a four-year follow-up. ScientificWorldJournal. 2014;2014:469609.CrossRef
35.
Brusini P, Tosoni C, Zeppieri M. Canaloplasty in corticosteroid-induced glaucoma. Preliminary results. J Clin Med. 2018;7:31.CrossRef
36.
Lommatzsch C, Heinz C, Heiligenhaus A, Koch JM. Canaloplasty in patients with uveitic glaucoma: a pilot study. Graefes Arch Clin Exp Ophthalmol. 2016;254:1325–30.CrossRef
37.
Brusini P, Tosoni C. Canaloplasty after failed trabeculectomy: a possible option. J Glaucoma. 2014;23:33–4.CrossRef
38.
Korber N. Canaloplasty after trabeculectomy. Ophthalmologe. 2015;112:332–6.CrossRef
39.
Xin C, Chen X, Shi Y, Wang H, Wang N. Modified canaloplasty: a new, effective, and safe option for glaucoma patients with a disrupted schlemm canal wall. J Glaucoma. 2016;25:798–801.CrossRef
40.
Xin C, Chen X, Shi Y, et al. One-year interim comparison of canaloplasty in primary open-angle glaucoma following failed filtering surgery with primary canaloplasty. Br J Ophthalmol. 2016;100:1692–6.CrossRef
41.
Grieshaber MC, Pienaar A, Olivier J, Stegmann R. Canaloplasty for primary open-angle glaucoma: long-term outcome. Br J Ophthalmol. 2010;94:1478–82.CrossRef
42.
Godfrey DG, Fellman RL, Neelakantan A. Canal surgery in adult glaucomas. Curr Opin Ophthalmol. 2009;20:116–21.CrossRef
43.
Hamanaka T, Kasahara K, Takemura T. Histopathology of the trabecular meshwork and Schlemm’s canal in primary angle-closure glaucoma. Invest Ophthalmol Vis Sci. 2011;52:8849–61.CrossRef
44.
Brusini P, Caramello G, Benedetti S, Tosoni C. Canaloplasty in open-angle glaucoma: mid-term results from a multicenter study. J Glaucoma. 2016;25:403–7.CrossRef
45.
Bull H, von Wolff K, Korber N, Tetz M. Three-year canaloplasty outcomes for the treatment of open-angle glaucoma: european study results. Graefes Arch Clin Exp Ophthalmol. 2011;249:1537–45.CrossRef
46.
Lewis RA, von Wolff K, Tetz M, et al. Canaloplasty: three-year results of circumferential viscodilation and tensioning of Schlemm canal using a microcatheter to treat open-angle glaucoma. J Cataract Refract Surg. 2011;37:682–90.CrossRef
47.
Lewis RA, von Wolff K, Tetz M, et al. Canaloplasty: circumferential viscodilation and tensioning of Schlemm canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults: two-year interim clinical study results. J Cataract Refract Surg. 2009;35:814–24.CrossRef
48.
Lewis RA, von Wolff K, Tetz M, et al. Canaloplasty: circumferential viscodilation and tensioning of Schlemm’s canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults: interim clinical study analysis. J Cataract Refract Surg. 2007;33:1217–26.CrossRef
49.
Grieshaber MC, Fraenkl S, Schoetzau A, Flammer J, Orgul S. Circumferential viscocanalostomy and suture canal distension (canaloplasty) for whites with open-angle glaucoma. J Glaucoma. 2011;20:298–302.CrossRef
50.
Gismondi M, Brusini P. Intracorneal hematoma after canaloplasty in glaucoma. Cornea. 2011;30:718–9.CrossRef
51.
Koch JM, Heiligenhaus A, Heinz C. Canaloplasty and transient anterior chamber haemorrhage: a prognostic factor? Klin Monbl Augenheilkd. 2011;228:465–7.CrossRef
52.
Tetz M, Koerber N, Shingleton BJ, et al. Phacoemulsification and intraocular lens implantation before, during, or after canaloplasty in eyes with open-angle glaucoma: 3-year results. J Glaucoma. 2015;24:187–94.CrossRef
53.
Fujita K, Kitagawa K, Ueta Y, et al. Short-term results of canaloplasty surgery for primary open-angle glaucoma in Japanese patients. Case Rep Ophthalmol. 2011;2:65–8.CrossRef
54.
Matlach J, Dhillon C, Hain J, et al. Trabeculectomy versus canaloplasty (TVC study) in the treatment of patients with open-angle glaucoma: a prospective randomized clinical trial. Acta Ophthalmol. 2015;93:753–61.CrossRef
55.
Palanca-Capistrano AM, Hall J, Cantor LB, et al. Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery. Ophthalmology. 2009;116:185–90.CrossRef
56.
Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998;126:487–497.
57.
Wong TT, Khaw PT, Aung T, et al. The singapore 5-Fluorouracil trabeculectomy study: effects on intraocular pressure control and disease progression at 3 years. Ophthalmology. 2009;116:175–84.CrossRef
58.
Voykov B, Szurman P, Dimopoulos S, Ziemssen F, Alnahrawy O. Micro-invasive suture trabeculotomy after canaloplasty: preliminary results. Clin Exp Ophthalmol. 2015;43:409–14.CrossRef
59.
Seuthe AM, Januschowski K, Szurman P. Micro-invasive 360-degree suture trabeculotomy after successful canaloplasty—one year results. Graefes Arch Clin Exp Ophthalmol. 2016;254:155–9.CrossRef
60.
Voykov B, Rohrbach JM. Revision procedures after canaloplasty. Ophthalmologe. 2016;113:910–3.CrossRef
61.
Khaimi MA, Dvorak JD, Ding K. An analysis of 3-year outcomes following canaloplasty for the treatment of open-angle glaucoma. J Ophthalmol. 2017;2017:2904272.CrossRef
62.
Ayyala RS, Chaudhry AL, Okogbaa CB, Zurakowski D. Comparison of surgical outcomes between canaloplasty and trabeculectomy at 12 months’ follow-up. Ophthalmology. 2011;118:2427–33.CrossRef
63.
Bruggemann A, Despouy JT, Wegent A, Muller M. Intraindividual comparison of Canaloplasty versus trabeculectomy with mitomycin C in a single-surgeon series. J Glaucoma. 2013;22:577–83.CrossRef
64.
Quaranta L, Biagioli E, Riva I, et al. Effect of trabeculectomy and canaloplasty on intra-ocular pressure modifications after postural changes in open-angle glaucoma. Acta Ophthalmol. 2014;92:e498–9.CrossRef
65.
Zhang B, Kang J, Chen X. A system review and meta-analysis of canaloplasty outcomes in glaucoma treatment in comparison with trabeculectomy. J Ophthalmol. 2017;2017:2723761.PubMedPubMedCentral
66.
Lin ZJ, Xu S, Huang SY, Zhang XB, Zhong YS. Comparison of canaloplasty and trabeculectomy for open angle glaucoma: a Meta-analysis. Int J Ophthalmol. 2016;9:1814–9.PubMedPubMedCentral
67.
Koerber NJ. Canaloplasty in one eye compared with viscocanalostomy in the contralateral eye in patients with bilateral open-angle glaucoma. J Glaucoma. 2012;21:129–34.PubMed
68.
Wagdy FM. Canaloplasty versus viscocanalostomy in primary open angle glaucoma. Electron Phys. 2017;9:3665–71.CrossRef
69.
Rekas M, Byszewska A, Petz K, Wierzbowska J, Junemann A. Canaloplasty versus non-penetrating deep sclerectomy—a prospective, randomised study of the safety and efficacy of combined cataract and glaucoma surgery; 12-month follow-up. Graefes Arch Clin Exp Ophthalmol. 2015;253:591–9.CrossRef
70.
Byszewska A, Junemann A, Rekas M. Canaloplasty versus nonpenetrating deep sclerectomy: 2-year results and quality of life assessment. J Ophthalmol. 2018;2018:2347593.CrossRef
Metadata
Title
Canaloplasty in the Treatment of Open-Angle Glaucoma: A Review of Patient Selection and Outcomes
Authors
Ivano Riva
Paolo Brusini
Francesco Oddone
Manuele Michelessi
Robert N. Weinreb
Luciano Quaranta
Publication date
01-01-2019
Publisher
Springer Healthcare
Published in
Advances in Therapy / Issue 1/2019
Print ISSN: 0741-238X
Electronic ISSN: 1865-8652
DOI
https://doi.org/10.1007/s12325-018-0842-6

Other articles of this Issue 1/2019

Advances in Therapy 1/2019 Go to the issue

Original Research

Safety and Efficacy of Bupivacaine HCl Collagen-Matrix Implant (INL-001) in Open Inguinal Hernia Repair: Results from Two Randomized Controlled Trials

Study Protocol

Design of a Study Assessing Disease Behaviour During the Peri-Diagnostic Period in Patients with Interstitial Lung Disease: The STARLINER Study

Review

Silodosin: An Update on Efficacy, Safety and Clinical Indications in Urology

Review

Recognising Lung Cancer in Primary Care

Original Research

Bridging the Gap Between Self-Reported and Claims-Derived Adherence Measures for Basal Insulin Among Patients with Type 2 Diabetes Mellitus

Case Series

Systemic Approach to Prevent Inadvertent Perfusion in Eyes with Extensive Choroidal Detachment, Suprachoroidal Fluid, and Hypotony During Pars Plana Vitrectomy

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits